Just remember no matter what games are played with the share price that Clinuvel is undervalued even at $30 and the chart I updated a few days ago with half yearly financials shows this (see below). Even though the company is undervalued just on EPP which is right at the beginning of super US growth, the real prize is DNA REPAIR, XP, skin cancer, Stroke, Vitiligo and whatever else is to come. EPP is the 'proof of concept' but what a way to achieve that by allowing sufferers of that terrible disease to live freely and building a cash cow to fund everything else at the same time.
All IMO DYOR
Shorts - general info, page-338
-
- There are more pages in this discussion • 411 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.65 |
Change
0.590(3.92%) |
Mkt cap ! $783.7M | |||
| Open | High | Low | Value | Volume |
| $15.27 | $15.65 | $15.05 | $967.0K | 62.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 227 | $15.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.65 | 999 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |